Background Venous thromboembolism (VTE), although rare, is a major cause of maternal
mortality and morbidity. Some women are at increased risk of VTE during pregnancy and the …

Objectives To compare and rank currently available pharmacological interventions for the
prevention of recurrent miscarriage (RM) in women with antiphospholipid syndrome (APS) …

Aspirin and heparin are widely used to reduce the risk of recurrent pregnancy loss in women
with antiphospholipid syndrome. This practice is based on only a few intervention studies …

Background The use of low-dose aspirin (LDA) and heparin has improved pregnancy
outcomes in women with antiphospholipid syndrome (APS). However, 20–30% still have …

To assess the roles of the low molecular weight heparin (LMWH) on recurrent pregnancy
loss (RPL). The relevant studies of all randomized controlled trials (RCTs) were retrieved …

The present study aimed to review relevant, randomized, controlled trials in order to
determine the effects of aspirin and heparin treatment on recurrent spontaneous abortion …

Background We performed a systematic review and meta-analysis to assess the efficacy and
safety of heparin for preventing adverse obstetrical outcomes in pregnant women with …

Background: Antiphospholipid antibody syndrome (APS) is a systemic, autoimmune,
prothrombotic disease characterized by persistent antiphospholipid antibodies, thrombosis …

Antiphospholipid syndrome (APS) increases the risk of obstetric complications, but risk
factors for pregnancy morbidity in women with APS remain incompletely characterized. This …

Background Antiphospholipid syndrome is associated with recurrent pregnancy loss. Low-
molecular-weight heparin (LMWH) and/or aspirin (ASA) prophylaxis during pregnancy to …